Mirum Pharmaceuticals, Inc.
Clinical trials sponsored by Mirum Pharmaceuticals, Inc., explained in plain language.
-
New shot aims to tame tough liver virus
Disease control OngoingThis study is testing a new injectable drug called brelovitug (BJT-778) to control chronic Hepatitis D virus infection. About 150 participants will receive either a weekly shot, a monthly shot, or be in a group that waits 24 weeks before starting treatment. The main goal is to se…
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug trial targets debilitating itch in liver disease
Symptom relief OngoingThis study is testing whether an investigational drug called volixibat can safely reduce the severe itching (pruritus) experienced by people with primary sclerosing cholangitis (PSC), a chronic liver disease. The trial involves 182 participants who will receive either the drug or…
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC